Previous studies have confirmed that the expression of GLUT1 in human bladder cancer is associated with poor prognosis and a low survival rate [35], which was considered a marker of aggressive biologic potential for BLCA meanwhile [36]. This evidence concerns the gene SLC2A1 and urinary bladder cancer.